- According to estimates from 10 analysts, Arrowhead Pharmaceuticals, Inc. stock's average price target has risen from $107.6 to $110.2, with forecasts ranging from $95 to $126 per share
- Based on the Aug. 4 closing price, the updated target implies approximately 23% potential upside
- Consensus rating remains at “Buy” across 14 covering analysts, with 13 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Arrowhead Pharmaceuticals, Inc. on the , and track all previous and future analyst recommendations for Arrowhead Pharmaceuticals, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.